000 03082cam  2200469zi 4500
0019.899811
003CaOODSP
00520221107175225
006m     o  d f      
007cr cn|||||||||
008210514t20212021onc     o    f000 0 eng d
020 |a9780660388830
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH14-366/2021E-PDF
24500|aIndustry advisory roundtable on COVID-19 testing : |bborder measures : response to the Expert Panel Report on "Priority strategies to optimize testing and quarantine at Canada’s borders".
24610|aResponse to the Expert Panel Report on "Priority strategies to optimize testing and quarantine at Canada’s borders"
24613|aCoronavirus disease (COVID-19) : |bIndustry advisory roundtable on COVID-19 testing : border measures : response to the Expert Panel Report on "Priority strategies to optimize testing and quarantine at Canada’s borders"
24617|aIndustry advisory roundtable on COVID-19 testing : |bborder measures
264 1|aOttawa, ON : |bGovernment of Canada = Gouvernement du Canada, |c2021.
264 4|c©2021
300 |a1 online resource (iii, 5 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aCover title.
500 |aIssued also in HTML format.
500 |aIssued by Health Canada.
500 |a"Publication date: May 2021."
500 |aAt head of title: Coronavirus disease (COVID-19).
500 |aIssued also in French under title: Table ronde consultative de l’industrie sur les tests de dépistage de la COVID‑19 : mesures frontalières : réponse au rapport « Stratégies prioritaires pour optimiser les tests et la quarantaine aux frontières du Canada » publié par le Comité consultatif d’experts.
520 |a"The Roundtable recognizes the effort required to implement plans for easing border restrictions, given rapidly evolving public health circumstances and emerging variants of concern. Prompt action is needed to design and implement a border measures plan that reduces the risk of the virus spreading while proactively moving towards economic recovery"--Executive Summary, page 1.
650 0|aBorder crossing|xGovernment policy|zCanada.
650 0|aQuarantine|xGovernment policy|zCanada.
650 0|aCOVID-19 (Disease)|xGovernment policy|zCanada.
7101 |aCanada. |bHealth Canada, |eissuing body.
77508|tTable ronde consultative de l’industrie sur les tests de dépistage de la COVID‑19 : |w(CaOODSP)9.899812
795 |tPriority strategies to optimize testing and quarantine at Canada's borders.|w(CaOODSP)9.898376
85640|qPDF|s1.06 MB|uhttps://publications.gc.ca/collections/collection_2021/sc-hc/H14-366-2021-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/medical-devices/testing-outreach-collaboration/industry-advisory-roundtable/reports/border-measures.html